IGF2BP1 and neuroblastoma: BTYNB decreased neuroblastoma cell viability, as previously reported [56], disturbed MYCN mRNA association with IGF2BP1 and impaired MYCN at only modest reduction of IGF2BP1 (Fig. 2e-g; Supplementary Figs. 2d, e, and 3b).